Abstract:Ethnopharmacological relevance: Aristolochic acid nephropathy (AAN) is a kidney disease caused by the administration of plants containing aristolochic acids (AAs). Aristolochic acid I (AAI) is the main toxic component in AAs. Organic anion transporters (OATs) 1 and 3 mediate the renal uptake of AAI, which is related to AAN. In our previous study, we found that anthraquinones derived from the herbal medicine Rheum palmatum L. (RP) inhibited both OAT1 and OAT3, with rhein exhibiting the greatest potency among the components. Aim of the study: This study aimed to investigate the effects of rhein and RP extract on the pharmacokinetics and tissue distribution of AAI and its demethylated metabolite (8-hydroxy-aristolochic acid I [AAIa]) in rats. Materials and methods: Rhein and RP extract were used as OAT inhibitors, and AAI was used as the toxic substrate. The pharmacokinetics and tissue distribution of AAI and AAIa in rats following the intravenous injection of AAI (10 mg/kg) in the presence and absence of rhein (100 mg/kg) or RP extract (5 g crude drug/kg) were investigated. Results: Co-administration with rhein increased AUC(0-infinity) of AAI and AAIa by 39 and 44%, respectively. However, the renal level of AAI was decreased to 50, 42, and 58% of those in rats treated with AAI alone at 5, 10, and 20 min after treatment, respectively, and the renal level of AAIa was decreased to 58, 57, and 61% of the level in rats treated with AAI alone, respectively, at these time points. In the RP extract co-administration group, AAI and AAIa plasma exposure was not significantly increased, but renal accumulation of AAI was decreased to 63, 58, and 68% of that in rats treated with AAI alone at 5, 10, and 20 min after treatment, respectively. In addition, renal accumulation of AAIa was decreased to 74, 70, and 70% of that in rats treated with AAI alone at 5, 10, and 20 min after treatment, respectively. Conclusions: This study indicated that co-administration with rhein significantly increased the plasma exposure of AAI and AAIa while decreased their renal accumulation in rats. RP extract reduced the renal accumulation of AAI and AAIa, but have no significant effect on their plasma exposure levels in rats.

Study on the Nitric Oxide Generating Effects from Aristolochic Acid in Vitro

Study on DNA Damage Induced by Aristolochic Acid in Vitro

Kinetics of aristolochic acid I after oral administration of Radix Aristolochiae or Guanxinsuhe preparation in canines.

Effect of Nitric Oxide on Catharanthine Production and Growth Ofcatharanthus Roseus Suspension Cells

Nitric oxide inhalation inhibits inducible nitric oxide synthase but not nitrotyrosine formation and cell apoptosis in rat lungs with meconium-induced injury

Increased Oxidative Stress in Rats with Chronic Nitric Oxide Depletion: Measurement of Urinary 8-Hydroxy-2'-deoxyguanosine Excretion.

Visceral leishmaniasis in human immunodeficiency virus disease.

Study on the Technology of Nitric Oxide (no) Detection in Vitro and in Vivo

Study on Rapid Determination of Aristolochic Acids in Aristolochia Medicinal Plants.

Comparative Analysis of Aristolochic Acids in Aristolochia Medicinal Herbs and Evaluation of Their Toxicities

Differential cytotoxic effects of denitroaristolochic acid II and aristolochic acids on renal epithelial cells.

[Studies on Pharmacodynamic Characteristics of Aristolochic Acid I in Rats].

Metabolic profiling using combined GC-MS and LC-MS provides a systems understanding of aristolochic acid-induced nephrotoxicity in rat.

Effects of Rhein and Rheum Palmatum L. Extract on the Pharmacokinetics and Tissue Distribution of Aristolochic Acid I and Its Demethylated Metabolite in Rats.

Characterization of two putative norlaudanosoline methyltransferases from Aristolochia debilis

In vivo Detection of Nitric Oxide in Rat Hippocampus

Investigation of the Metabolism and Reductive Activation of Carcinogenic Aristolochic Acids in Rats.

Rapid Characterization and Pharmacokinetic Study of Aristolochic Acid Analogues Using Ion Mobility Mass Spectrometry.

Liquid Chromatography/mass Spectrometry for Metabonomics Investigation of the Biochemical Effects Induced by Aristolochic Acid in Rats: the Use of Information‐dependent Acquisition for Biomarker Identification

Nitric Oxide Regulation of Myocardial O-2 Consumption and Hep Metabolism

Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry.